newsfilter
← Latest News
Business Wire·

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Personalised treatment plans pair medication with unlimited Care Team support, nutrition and lifestyle guidance, and Canadian medical expertise, starting at $149/month Hims & Hers Health, Inc. (NYSE:HIMS), the